Effect of the addition of insulin-transferrin-selenium and/or L-ascorbic acid to the in vitro maturation of prepubertal bovine oocytes on cytoplasmic maturation and embryo development.
This study examines the effects of adding insulin-transferrin-selenium (ITS) and/or L-ascorbic acid (ASC) to a conventional medium for maturing prepubertal calf oocytes on chromosome organization, cortical granule (CG) distribution, and embryo development to the blastocyst stage. Cumulus-oocyte complexes (COCs) were matured in medium TCM 199 containing PVA and EGF (control), and supplemented with ITS and/or ASC for 12 or 24 h at 38.5 °C in a 5% CO(2) atmosphere. Calf oocytes matured with ITS + ASC or ASC for 12 h showed significantly higher percentages of peripherally distributed CG (83.3% and 86.2% respectively) than control oocytes (71.4%) or those matured with ITS alone (71.4%). No effects on chromosome organization were detected. Conversely, 24 h of supplementation did not affect CG distribution patterns, while the addition of ASC gave rise to significantly higher percentages of oocytes showing a normal alignment of their chromosomes (72.9%) compared to controls (58.7%). At 48 hpi, similar cleavage rates were observed among treatments regardless of the treatment time. However, the presence of ITS + ASC for 12 h rendered significantly higher blastocyst rates than those recorded in the remaining groups. Supplementation for 24 h with ITS or ITS + ASC had no significant effects on the percentage of blastocysts obtained, while the presence of ASC significantly reduced the proportions of embryos developing to the blastocyst stage. Our data suggest that ITS plus L-ascorbic acid supplementation during the first 12 h of in vitro maturation improves cytoplasm maturation and the developmental competence of embryos produced from prepubertal calf oocytes.
Córdova
B
B
Departament de Medicina i Cirurgia Animals, Universitat Autònoma de Barcelona, Bellaterra, Spain.
Morató
R
R
Izquierdo
D
D
Paramio
T
T
Mogas
T
T
D000367:Age Factors; D000818:Animals; D001205:Ascorbic Acid / Q000494:pharmacology*; D001755:Blastocyst / Q000187:drug effects* / Q000378:metabolism; D002417:Cattle / Q000196:embryology*; D033481:Chromosomes, Mammalian / Q000187:drug effects; D056744:Cyclin B1 / Q000235:genetics / Q000378:metabolism; D046149:Embryo Culture Techniques / Q000662:veterinary*; D047108:Embryonic Development / Q000187:drug effects*; D005260:Female; D007328:Insulin / Q000494:pharmacology*; D008297:Male; D012643:Selenium / Q000494:pharmacology*; D012741:Sexual Maturation; D014168:Transferrin / Q000494:pharmacology*
D056744:Cyclin B1; D007328:Insulin; D014168:Transferrin; D012643:Selenium; D001205:Ascorbic Acid